ASMA BADAR: Open Payments
NPI 1558393462 · GALLOWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 31 payments from 7 companies in 2025. Trend: 2023 $33 · 2024 $106 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $146 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $15 |
Products named: ARISTADA, INVEGA, ABILIFY ASIMTUFII, COBENFY, UZEDY, REXULTI, INGREZZA.
Industry payments across NJ — which companies pay providers there.
